NEXGEL, Inc. (NASDAQ:NXGL) Short Interest Update
by Amy Steele · The Cerbat GemNEXGEL, Inc. (NASDAQ:NXGL – Get Free Report) was the recipient of a large increase in short interest in August. As of August 31st, there was short interest totalling 15,600 shares, an increase of 23.8% from the August 15th total of 12,600 shares. Approximately 0.3% of the company’s shares are sold short. Based on an average daily volume of 47,600 shares, the short-interest ratio is presently 0.3 days.
NEXGEL Stock Down 1.9 %
NASDAQ:NXGL traded down $0.05 during trading hours on Tuesday, hitting $2.65. 16,086 shares of the stock traded hands, compared to its average volume of 29,280. The firm has a 50 day moving average price of $2.66 and a 200 day moving average price of $2.44. The firm has a market cap of $16.50 million, a price-to-earnings ratio of -4.82 and a beta of 0.77. NEXGEL has a fifty-two week low of $1.46 and a fifty-two week high of $3.24. The company has a current ratio of 1.36, a quick ratio of 0.81 and a debt-to-equity ratio of 0.22.
NEXGEL (NASDAQ:NXGL – Get Free Report) last announced its quarterly earnings data on Monday, August 19th. The company reported ($0.14) EPS for the quarter. The business had revenue of $1.44 million for the quarter. NEXGEL had a negative return on equity of 64.21% and a negative net margin of 67.80%.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in NEXGEL stock. Northeast Financial Group Inc. bought a new stake in shares of NEXGEL, Inc. (NASDAQ:NXGL – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 11,848 shares of the company’s stock, valued at approximately $32,000. Northeast Financial Group Inc. owned 0.19% of NEXGEL as of its most recent SEC filing. 2.21% of the stock is owned by hedge funds and other institutional investors.
NEXGEL Company Profile
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
Recommended Stories
- Five stocks we like better than NEXGEL
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- What is a SEC Filing?
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What is the FTSE 100 index?
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker